Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 16 studies | 49% ± 20% | |
| oligodendrocyte | 14 studies | 40% ± 15% | |
| endothelial cell | 13 studies | 30% ± 14% | |
| glutamatergic neuron | 12 studies | 48% ± 25% | |
| oligodendrocyte precursor cell | 8 studies | 21% ± 7% | |
| GABAergic neuron | 8 studies | 43% ± 17% | |
| neuron | 6 studies | 40% ± 16% | |
| interneuron | 6 studies | 39% ± 10% | |
| fibroblast | 6 studies | 20% ± 4% | |
| endothelial cell of lymphatic vessel | 6 studies | 26% ± 8% | |
| epithelial cell | 5 studies | 22% ± 5% | |
| vein endothelial cell | 5 studies | 28% ± 18% | |
| granule cell | 4 studies | 28% ± 10% | |
| GABAergic interneuron | 3 studies | 30% ± 10% | |
| GABAergic amacrine cell | 3 studies | 19% ± 4% | |
| connective tissue cell | 3 studies | 17% ± 1% | |
| transit amplifying cell | 3 studies | 31% ± 14% | |
| brush cell | 3 studies | 33% ± 11% | |
| goblet cell | 3 studies | 18% ± 1% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 28% ± 7% | |
| kidney loop of Henle epithelial cell | 3 studies | 22% ± 6% | |
| renal principal cell | 3 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 8879.47 | 2642 / 2642 | 99% | 97.47 | 701 / 705 |
| prostate | 100% | 2286.45 | 244 / 245 | 100% | 57.55 | 501 / 502 |
| ovary | 100% | 2080.01 | 180 / 180 | 99% | 50.23 | 425 / 430 |
| intestine | 100% | 2414.47 | 964 / 966 | 95% | 46.78 | 500 / 527 |
| pancreas | 99% | 2389.78 | 326 / 328 | 92% | 27.83 | 164 / 178 |
| stomach | 91% | 1423.26 | 328 / 359 | 96% | 45.69 | 275 / 286 |
| kidney | 100% | 3216.69 | 89 / 89 | 87% | 35.28 | 782 / 901 |
| thymus | 99% | 1452.88 | 645 / 653 | 77% | 14.67 | 466 / 605 |
| liver | 96% | 1509.86 | 217 / 226 | 68% | 40.91 | 277 / 406 |
| esophagus | 93% | 1240.58 | 1345 / 1445 | 69% | 24.61 | 127 / 183 |
| lung | 96% | 1431.23 | 554 / 578 | 64% | 18.30 | 743 / 1155 |
| breast | 100% | 1769.99 | 457 / 459 | 60% | 19.67 | 675 / 1118 |
| adrenal gland | 67% | 628.42 | 174 / 258 | 86% | 34.50 | 197 / 230 |
| uterus | 99% | 2319.11 | 168 / 170 | 52% | 21.23 | 237 / 459 |
| bladder | 100% | 1756.05 | 21 / 21 | 50% | 17.89 | 251 / 504 |
| spleen | 100% | 2221.90 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 1907.16 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| skin | 70% | 1187.55 | 1263 / 1809 | 24% | 7.95 | 114 / 472 |
| heart | 91% | 1182.05 | 780 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 71% | 814.71 | 954 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 18.69 | 28 / 45 |
| eye | 0% | 0 | 0 / 0 | 50% | 8.54 | 40 / 80 |
| muscle | 25% | 204.74 | 199 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 3.05 | 6 / 29 |
| peripheral blood | 1% | 7.82 | 8 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043149 | Biological process | stress fiber assembly |
| GO_0008360 | Biological process | regulation of cell shape |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FAM171A1 |
| Protein name | Family with sequence similarity 171 member A1 Protein FAM171A1 (Astroprincin) (APCN) Alternative protein FAM171A1 |
| Synonyms | C10orf38 APCN |
| Description | FUNCTION: Involved in the regulation of the cytoskeletal dynamics, plays a role in actin stress fiber formation. . |
| Accessions | ENST00000378116.9 Q5VUB5 L8E7C4 ENST00000455654.1 Q5SW12 |